Success Metrics

Completion Rate
0%(0/1)
Active Trials
1(33%)
Terminated
1(33%)

Phase Distribution

Ph not_applicable
3
100%

Phase Distribution

0

Early Stage

0

Mid Stage

0

Late Stage

Phase Distribution3 total trials
N/ANon-phased studies
3(100.0%)

Highest Phase Reached

Unknown

Trial Status & Enrollment

Completion Rate

0.0%

0 of 1 finished

Non-Completion Rate

100.0%

1 ended early

Currently Active

1

trials recruiting

Total Trials

3

all time

Status Distribution
Active(1)
Terminated(1)
Other(1)

Detailed Status

Terminated1
unknown1
Recruiting1

Development Timeline

Analytics

Development Status

Total Trials
3
Active
1
Success Rate
0.0%
Most Advanced
N/A

Trials by Phase

N/A3 (100.0%)

Trials by Status

terminated133%
unknown133%
recruiting133%

Recent Activity

1 active trials
Showing 3 of 3
recruitingnot_applicable

Change of Adipose Tissues and Triglyceride After Bariatric Surgery or Life-style Intervention

NCT03875625
terminatednot_applicable

Alternation of Non-alcoholic Fatty Liver Disease (NAFLD) and Cardiovascular Risks After Liftestyle Modification: A Ultrasound Attenuation Imaging-Based Study

NCT04440540
unknownnot_applicable

Lifestyle Modification for MAFLD Based on TTM

NCT04871880

Clinical Trials (3)

Showing 3 of 3 trials
NCT03875625Not Applicable

Change of Adipose Tissues and Triglyceride After Bariatric Surgery or Life-style Intervention

Recruiting
NCT04440540Not Applicable

Alternation of Non-alcoholic Fatty Liver Disease (NAFLD) and Cardiovascular Risks After Liftestyle Modification: A Ultrasound Attenuation Imaging-Based Study

Terminated
NCT04871880Not Applicable

Lifestyle Modification for MAFLD Based on TTM

Unknown

All 3 trials loaded

Drug Details

Intervention Type
BEHAVIORAL
Total Trials
3